Gliflozins on HF in Regurgitant Rheumatic Heart
NCT06097585 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-10-30
Summary
The objective of this trial is to detect impact of Gliflozin on patients with heart failure due to reurgitant rheumatic valve disease
Conditions
- Rheumatic Heart Disease
- Heart Failure
Interventions
- DRUG
-
SGLT2 inhibitor
case control study in which group will receive SGLT2I and group will not , to detect impact of the drug in changing NYHA class for heart failure and echographic parameter
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Doaa A Fouad, MD · Assiut University
-
Magdy A Algowhary, MD · Assiut University
-
Ahmed G Bakry, MD · South Valley University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-01
- Primary Completion
- 2024-12-01
- Completion
- 2025-04-01
More Related Trials
-
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
NCT05600387 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Initiation of ARNi and SGLT2i in Patients With HFrEF
NCT05989503 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
NCT06111768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dapagliflozin Effect on Rheumatic Mitral Stenosis
NCT05618223 ·Status: UNKNOWN ·Phase: PHASE3
-
Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
NCT06433050 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
EMPagliflozin After Aortic Valve Replacement
NCT06171802 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
NCT05305911 ·Status: RECRUITING ·Phase: PHASE2
-
Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)
NCT04490681 ·Status: UNKNOWN ·Phase: PHASE3
-
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
NCT05764057 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction
NCT05672134 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients
NCT07186153 ·Status: NOT_YET_RECRUITING
-
Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
NCT05934071 ·Status: UNKNOWN
-
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling
NCT05606718 ·Status: UNKNOWN ·Phase: PHASE4
-
ISGLT2 in Patients Without DM With Acute MI
NCT06903754 ·Status: COMPLETED
-
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
NCT02653482 ·Status: COMPLETED ·Phase: PHASE4
-
Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation
NCT06759909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction
NCT05420285 ·Status: UNKNOWN ·Phase: PHASE2
-
SGLT2 Inhibitor for Severe Tricuspid Regurgitation
NCT05686616 ·Status: UNKNOWN ·Phase: NA
-
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
NCT03416270 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention
NCT05241431 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
NCT03027960 ·Status: COMPLETED ·Phase: PHASE1
-
Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients
NCT03271879 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Acute and Chronic Empagliflozin Heart Failure
NCT05553938 ·Status: RECRUITING ·Phase: PHASE1
-
Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction
NCT05849766 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
NCT05636176 ·Status: RECRUITING ·Phase: PHASE3